EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference
October 05, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Oct. 05, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
Research Nester Logo.jpg
Perineural Therapy Market revenue to hit USD 1 Billion by 2035, says Research Nester
September 27, 2023 05:00 ET | Research Nester
New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global perineural therapy market size is slated to expand at ~15% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 1...
EC-Logo-2018_TM_CMYK.jpg
electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology
September 26, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Participate in the LD Micro Main Event XVI Conference
September 25, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference
September 21, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
EC-Logo-2018_TM_CMYK.jpg
electroCore Announces Second Quarter 2023 Financial Results
August 09, 2023 16:05 ET | electroCore, Inc.
Record second quarter 2023 net sales of $3.6 million, an increase of approximately 65% over second quarter 2022 Company to host a conference call and webcast today, August 9, 2023 at 4:30 PM EDT ...
EC-Logo-2018_TM_CMYK.jpg
electroCore to Announce Second Quarter Financial Results on Wednesday, August 9
August 01, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
EC-Logo-2018_TM_CMYK.jpg
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
July 25, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the publication of a peer reviewed...
EC-Logo-2018_TM_CMYK.jpg
electroCore Expands Intellectual Patent Portfolio for nVNS Technology
July 18, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
EC-Logo-2018_TM_CMYK.jpg
electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC
July 13, 2023 08:00 ET | electroCore, Inc.
ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband,...